{
  "id": 264070,
  "title": "Latigo IPO raises nearly $350M for pain drug development",
  "url": "https://urgent.news/2026/08/07/latigo-ipo-raises-nearly-350m-for-pain-drug-development",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-07T12:00:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/latigo-ipo-public-biotech-pain-drug-nasdaq/827300/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The company could rival Vertex and Lilly in the burgeoning market for non-opioid, ion-channel-blocking pain drugs. Its offering also adds to a recent and significant uptick in large biotech IPOs.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}